FDA Approved: PANRETIN — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approved a supplemental application for PANRETIN (alitretinoin) filed by Advanz Pharma (US) Corp. The submission status is AP, indicating approval of the su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• PANRETIN (ALITRETINOIN)

Snippet

SUPPL AP for PANRETIN (ALITRETINOIN)